Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $92
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Ryan MacDonald maintains a Buy rating on Tenet Healthcare (NYSE:THC) and raises the price target from $84 to $92.
June 20, 2023 | 1:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities maintains a Buy rating on Tenet Healthcare and raises the price target from $84 to $92.
The raised price target by Truist Securities analyst Ryan MacDonald indicates a positive outlook for Tenet Healthcare's stock. This news is likely to have a positive impact on the stock price in the short term as it shows increased confidence in the company's performance and potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100